 |
|||||||||||||||
|
|
|||||||||||||||
|
 |
|||
| Spring Meeting Trial Reports: 2011 / 2010 / 2009 | |||
| ID | Study Title | Status | |
| IND.173 | A Phase I/II Study of AZD0530 in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer MORE... | Permanently Closed | |
| IND.187 | A Phase I Study Of AZD2281 In Combination With Irinotecan In Patients With Locally Advanced or Metastatic Incurable Colorectal Cancer MORE... | On Hold | |
| BI.1 | Phase III Trial Of Combined Gemcitabine Plus Capecitabine Chemotherapy Versus Gemcitabine Alone In Advanced Biliary Cancer MORE... | Permanently Closed | |
|
CO.13 NCCTG 9741 |
A Randomized Phase III Trial of Combinations of Oxaliplatin (OXAL), 5-fluorouracil (5-FU), and Irinotecan (CPT-11) as Initial Treatment of Patients with Advanced Adenocarcinoma of the Colon and Rectum MORE... | Closed | |
|
CO.14 CALGB 9581 |
Phase III Randomized Study of Adjuvant Immunotherapy with Monoclonal Antibody 17-1A versus No Adjuvant Therapy Following Resection for Stage II (Modified Astler-Coller B2) Adenocarcinoma of the Colon MORE... | Permanently Closed | |
|
CO.16 MRC CR07 |
A Medical Research Council Colorectal Cancer Working Party Randomized Trial Comparing Pre-Operative Radiotherapy and Selective Post-Operative Chemoradiotherapy in Rectal Cancer MORE... | Closed | |
| CO.17 | A Phase III Randomized Study of Cetuximab (Erbitux TM, C225) and Best Supportive Care versus Best Supportive Care in Patients with Pretreated Metastatic Epidermal Growth Factor Receptor (EGFR) - Positive Colorectal Carcinoma MORE... | Permanently Closed | |
| CO.20 | A Phase III Randomized Study of Brivanib Alaninate (BMS-582664) in Combination with Cetuximab (Erbitux) Versus Placebo in Combination with Cetuximab (Erbitux) in Patients With K-Ras Wild Type Tumours Previously Treated With Combination Chemotherapy for Metastatic Colorectal Carcinoma MORE... | Closed | |
| CO.21 | A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients with High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (Challenge) MORE... | Open | |
|
CRC.2 NCCTG 0147 |
A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer MORE... | Closed | |
|
CRC.3 ECOG 5202 |
A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers MORE... | Closed | |
|
CRC.4 ECOG 5204 |
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-Operative Chemoradiation MORE... | Closed | |
|
CRC.5 CALGB 80405 |
A Phase III Trial of Irinotecan/5-Fu/Leucovorin or Oxaliplatin/5-Fu/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum MORE... | Open | |
|
CRC.6 CALGB 80702 |
A Phase III Trial of 6 versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo For Patients With Resected Stage III Colon Cancer MORE... | Open | |
|
ES.2 TROG 0301 |
A Randomized Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated with Radiotherapy versus Chemo-Radiotherapy MORE... | Open | |
|
GAC.1 CALGB 80101 |
Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients with Gastric or Gastroesophageal Adenocarcinoma MORE... | Closed | |
|
HEC.1 CALGB 80802 |
Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) MORE... | Open | |
|
NEC.2 CALGB 80701 |
Randomized Phase II Study of Everlimus Alone versus Everolimus Plus Bevacizumab in Patients with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumours MORE... | Open | |
|
PA.2 ESPAC ESPAC-3 (v2) |
Phase III Adjuvant Trial in Pancreatic Cancer Comparing (1) 5FU and D-L Folinic Acid vs (2) Gemcitabine vs (3) No Adjuvant Treatment MORE... | Closed | |
| PA.3 | A Randomized Placebo Controlled Study of OSI-774 plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer MORE... | Permanently Closed | |
|
PAC.1 SWOG 0205 |
A Phase III Randomized Open-Label Study Comparing Gemcitabine plus Cetuximab (IMC-225) versus Gemcitabine as First Line Therapy of Patients with Advanced Pancreas Cancer MORE... | Permanently Closed | |
|
PAC.2 ECOG 4201 |
A Randomized Phase III Study of Gemcitabine in Combination with Radiation Therapy versus Gemcitabine Alone in Patients with Localized, Unresectable Pancreatic Cancer MORE... | Permanently Closed | |
| If you have any questions, comments or suggestions, please contact our |